Fact CheckerSign in

NCT06081387Recruiting

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment: the DIAVITEX Project

Source: ClinicalTrials.gov · Last updated 6 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
6 Jul 2023
Start date
1 Oct 2025
Primary completion date
1 Jan 2026
Lead sponsor
University Ramon Llull
NCT number
NCT06081387

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 1 Oct 2025 to the primary completion date, 1 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin)
  • Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention

Other

  • Female subjects who are pregnant
  • Patients who did not sign the informed consent

Who the study is looking for

  • Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database
  • Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months.
  • Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group)
  • Patients who signed the informed consent
  • Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes)

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CAP Sant Rafael
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.